![Osami Kono](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Osami Kono
Director/Board Member at Luxonus Co., Ltd.
Profile
Osami Kono currently works at Luxonus Co., Ltd., as Director, EneCoat Technologies Co., Ltd., as Outside Director from 2018, Rege Nephro Co. Ltd., as Outside Director, and Kyoto University Innovation Capital Co., Ltd., as Investment Manager from 2016.
Osami Kono active positions
Companies | Position | Start |
---|---|---|
Kyoto University Innovation Capital Co., Ltd.
![]() Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Private Equity Investor | 01/04/2016 |
EneCoat Technologies Co., Ltd.
![]() EneCoat Technologies Co., Ltd. SemiconductorsElectronic Technology EneCoat Technologies Co., Ltd. is a company based in Kyoto, Japan that focuses on developing materials for perovskite solar cells and manufacturing modules. The Japanese company aims to promote the effective use of natural energy and protect the environment to create a better future. EneCoat Technologies Co. was founded in 2018 by Atsushi Wakamiya and Naoya Kato, with Naoya Kato serving as the CEO since then. | Director/Board Member | 01/12/2018 |
Luxonus Co., Ltd.
![]() Luxonus Co., Ltd. Electronics/AppliancesConsumer Durables Luxonus Co., Ltd. manufactures photo acoustic imaging products. The company is based in Kawasaki, Japan. The Japanese company was founded by Sadakazu Aiso. | Director/Board Member | - |
Rege Nephro Co. Ltd.
![]() Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Kyoto University Innovation Capital Co., Ltd.
![]() Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Finance |
Luxonus Co., Ltd.
![]() Luxonus Co., Ltd. Electronics/AppliancesConsumer Durables Luxonus Co., Ltd. manufactures photo acoustic imaging products. The company is based in Kawasaki, Japan. The Japanese company was founded by Sadakazu Aiso. | Consumer Durables |
EneCoat Technologies Co., Ltd.
![]() EneCoat Technologies Co., Ltd. SemiconductorsElectronic Technology EneCoat Technologies Co., Ltd. is a company based in Kyoto, Japan that focuses on developing materials for perovskite solar cells and manufacturing modules. The Japanese company aims to promote the effective use of natural energy and protect the environment to create a better future. EneCoat Technologies Co. was founded in 2018 by Atsushi Wakamiya and Naoya Kato, with Naoya Kato serving as the CEO since then. | Electronic Technology |
Rege Nephro Co. Ltd.
![]() Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Commercial Services |
- Stock Market
- Insiders
- Osami Kono